Six months versus 12 months dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction (DAPT-STEMI): randomised, multicentre, non-inferiority trial

E Kedhi; E Fabris; M Ent; P Buszman; C Birgelen; V Roolvink; A Zurakowski; CE Schotborgh; JCA Hoorntje; CH Eek; S Cook; M Togni; M Meuwissen; N van Royen; R Vliet; H Wedel; R Delewi; Felix Zijlstra

doi:10.1136/bmj.k3793

Six months versus 12 months dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction (DAPT-STEMI): randomised, multicentre, non-inferiority trial

E Kedhi, E Fabris, M Ent, P Buszman, C Birgelen, V Roolvink, A Zurakowski, CE Schotborgh, JCA Hoorntje, CH Eek, S Cook, M Togni, M Meuwissen, N van Royen, R Vliet, H Wedel, R Delewi, Felix Zijlstra

Cardiology

Research output: Contribution to journal › Article › Academic › peer-review

95 Citations (Scopus)

6 Downloads (Pure)

Original language	Undefined/Unknown
Article number	k3793
Journal	BMJ-British medical journal
Volume	363
DOIs	https://doi.org/10.1136/bmj.k3793
Publication status	Published - 2018

Access to Document

10.1136/bmj.k3793

REPUB_110891-OA.pdfFinal published version, 360 KB

http://hdl.handle.net/1765/110891

Cite this

Kedhi, E., Fabris, E., Ent, M., Buszman, P., Birgelen, C., Roolvink, V., Zurakowski, A., Schotborgh, CE., Hoorntje, JCA., Eek, CH., Cook, S., Togni, M., Meuwissen, M., van Royen, N., Vliet, R., Wedel, H., Delewi, R., & Zijlstra, F. (2018). Six months versus 12 months dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction (DAPT-STEMI): randomised, multicentre, non-inferiority trial. BMJ-British medical journal, 363, [k3793]. https://doi.org/10.1136/bmj.k3793

@article{2ef751071bf148dfb3b5031297c5e517,

title = "Six months versus 12 months dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction (DAPT-STEMI): randomised, multicentre, non-inferiority trial",

author = "E Kedhi and E Fabris and M Ent and P Buszman and C Birgelen and V Roolvink and A Zurakowski and CE Schotborgh and JCA Hoorntje and CH Eek and S Cook and M Togni and M Meuwissen and {van Royen}, N and R Vliet and H Wedel and R Delewi and Felix Zijlstra",

year = "2018",

doi = "10.1136/bmj.k3793",

language = "Undefined/Unknown",

volume = "363",

journal = "The BMJ",

issn = "0959-8146",

publisher = "BMJ Publishing Group",

}

Kedhi, E, Fabris, E, Ent, M, Buszman, P, Birgelen, C, Roolvink, V, Zurakowski, A, Schotborgh, CE, Hoorntje, JCA, Eek, CH, Cook, S, Togni, M, Meuwissen, M, van Royen, N, Vliet, R, Wedel, H, Delewi, R & Zijlstra, F 2018, 'Six months versus 12 months dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction (DAPT-STEMI): randomised, multicentre, non-inferiority trial', BMJ-British medical journal, vol. 363, k3793. https://doi.org/10.1136/bmj.k3793

TY - JOUR

T1 - Six months versus 12 months dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction (DAPT-STEMI): randomised, multicentre, non-inferiority trial

AU - Kedhi, E

AU - Fabris, E

AU - Ent, M

AU - Buszman, P

AU - Birgelen, C

AU - Roolvink, V

AU - Zurakowski, A

AU - Schotborgh, CE

AU - Hoorntje, JCA

AU - Eek, CH

AU - Cook, S

AU - Togni, M

AU - Meuwissen, M

AU - van Royen, N

AU - Vliet, R

AU - Wedel, H

AU - Delewi, R

AU - Zijlstra, Felix

PY - 2018

Y1 - 2018

U2 - 10.1136/bmj.k3793

DO - 10.1136/bmj.k3793

M3 - Article

SN - 0959-8146

VL - 363

JO - The BMJ

JF - The BMJ

M1 - k3793

ER -